Global coffee stocks may take years to recover, industry experts warned at the Coffee Dinner & Summit in Brazil, citing ongoing supply-demand imbalances and unpredictable climate patterns. Despite a promising harvest expected in Brazil—the world’s top coffee producer and exporter—experts say this won’t be enough to quickly rebuild depleted global inventories.
Coffee prices surged to record highs earlier this year due to consecutive years of supply deficits and stable or rising global demand. Industry leaders caution that the market needs at least two consecutive strong harvests to restore stock levels to those seen four years ago. However, achieving back-to-back bumper crops remains unlikely due to climate volatility and the natural biennial cycle of arabica coffee plants.
Luiz Fernando dos Reis, commercial superintendent at Cooxupe, Brazil’s largest coffee cooperative, said stockpiles won’t rebuild significantly in the short term. “We need at least two good harvests, and even then, the 2026/27 crop is likely to be followed by a weaker one,” he noted.
Charles Chiapolino, coffee research director at Louis Dreyfus Company, echoed this sentiment, saying it’s “almost impossible” to count on favorable weather conditions globally for two consecutive years.
German Bahamon, CEO of the Colombian Coffee Growers Federation, added that with demand holding steady or growing in many markets, “no one can build stocks right now.”
With rising consumption and volatile production, the global coffee market faces continued pressure. Even with Brazil’s optimistic harvest outlook, consumers may not see immediate price relief, and supply concerns are likely to persist well into the future.


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



